Hyderabad, India, 10th August 2020: Endiya Fund II has received a commitment of 75Cr ($10M approx.) from the International Finance Corporation (IFC), a member of the World Bank Group. IFC has also committed an additional US$ 10 million for direct co-investments alongside Endiya Fund II. The Partnership with IFC will provide Endiya portfolio companies with financial and strategic support resulting in increased access to growth opportunities and sustainable scalability.
“We are excited to have won IFC’s support and backing. We value IFC’s vast global presence across geographies that could offer future expansion markets for our portfolio companies” said, Sateesh Andra, Partner at Endiya Partners.
“We are also delighted to have a co-investment envelope from IFC that could be used to support our investees as they scale” he added
“Early Stage VC investment volumes in India are markedly lower than VC volumes in countries like the U.S. and China. Our investment in VC funds like Endiya helps mobilize capital from other LPs and brings that capital to path breaking early stage businesses,” said Jun Zhang, IFC Country Head, India. “Endiya Partners has demonstrated differentiation in access to high-quality Pre-Series A opportunities in Enterprise Technology and Healthtech sectors” he added.
Endiya Partners is a seed and early-stage venture capital firm investing in IP led Indian product start-ups that are globally relevant. Endiya’s current portfolio includes Darwinbox, Steradian Semiconductors, Kissht, SigTuple, and Myelin Foundry.
Endiya Fund II has a corpus target of Rs. 500 crores (US$ 65 million) and has already completed its first close at Rs. 280 crores (US$ 40 million) in May 2019. Limited Partners in the Fund include financial institutions, corporates, and family offices across India, Europe, and the U.S. Endiya Fund II will seek to invest in 16 – 20 start-ups, with an initial cheque size of US$ 500,000 to US$ 1 million in Seed/Pre-series A rounds and a planned investment of up to $5 million per company.
Founded in 2016 by Sateesh Andra, cardiologist-turned-investor Ramesh Byrapaneni, and Abhishek Srivastava, Endiya added Abhiram Katta to its top deck in 2018 and most recently expanded its Investments team by hiring Dipesh Chawla and Lakshmi Kancharla.
Endiya’s investment strategy addresses a funding gap in the venture capital spectrum in India between Angel and Series A investments, enabling entrepreneurs to find a value accretive partner to further the development of their vision to build a sustainable business model. Endiya is able to effectively add value through concept and market validation, product launch, team building, business model refinement, customer and partner acquisition and follow-on funding.
“While industry averages state that 30% of seed deals go on to raise follow on capital, 75% of Endiya’s Portfolio has raised follow on rounds. This showcases the team’s ability to source, screen, select and nurture quality early-stage startups”, adds Sateesh.
Endiya’s Fund I was a 2016 vintage fund with Rs.175 crores (US$ 25 million) corpus and invested in 12 portfolio companies.
About IFC
IFC—a sister organization of the World Bank and member of the World Bank Group—is the largest global development institution focused on the private sector in emerging markets. We work in more than 100 countries, using our capital, expertise, and influence to create markets and opportunities in developing countries. In fiscal year 2019, we invested more than $19 billion in private companies and financial institutions in developing countries, leveraging the power of the private sector to end extreme poverty and boost shared prosperity. For more information, visit www.ifc.org.
About Endiya
Hyderabad headquartered Endiya Partners’ is a seed and early-stage venture capital fund that invests in IP led Indian product startups that are globally relevant. Leveraging deep domain expertise along with vast entrepreneurial and operating experience, the Endiya team plays a key role in co-creating scalable (and sustainable) businesses. Endiya’s portfolio consists of disruptive and category-defining companies across Enterprise Technology and Healthcare sectors. The Fund also leverages the teams’ relationships and global presence with an appropriate set of VCs/strategic investors in Silicon Valley/SE Asia for its portfolio companies’ business development and exits.
Media Contact for Endiya: Sheela Panicker | +91 984 980 9594 | enright@enrightpr.com
